Toward the end of 2023, the economy started showing signs of stabilization and easing inflationary pressure as the Fed finally decided to keep interest rates unchanged. This is likely to benefit ...
The U.S. Food and Drug Administration (FDA) has approved Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Alvotech’s (NASDAQ:ALVO) Selarsdi (ustekinumab-aekn) injection as interchangeable with the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback